Wei R. Campbell is an intellectual property attorney with 15 years of experience on a broad range of IP matters in biotechnology, pharmaceuticals, and life sciences, including patent strategy, global patent portfolio development and management, due diligence, IP litigation, transactional matters, trademarks, copyrights, trade secrets, and client counseling. Prior to joining SanegeneBio, she held important positions at biopharmaceutical companies such as Alnylam and BeiGene, leading the development of comprehensive global patent portfolios including oligonucleotide therapies and small molecule drugs, and optimizing global market exclusivity for commercial assets and pipeline programs.